In individuals with obesity, high levels of circulating inflammatory markers and local inflammation of the microvasculature in skeletal muscle result in the inactivation of the insulin signaling pathway that can decrease the translocation of GLUT4 to the plasma membrane for glucose uptake [155] (Fig. 1). The gene discussed is SLC2A4; the disease is obesity due to melanocortin 4 receptor deficiency.